Professor Roland Grafström acts as a scientific advisor to the toxicology work at Misvik Biology. He received his Medical Science degree in 1980 and maintains currently a tenured Professor position at the Karolinska Institutet (KI), in Stockholm, Sweden. The CV lists ~150 peer-review research articles and several international prizes related to environmental medicine, toxicology and alternative methods research. He has vast experience in application of human cells to toxicity analyses, cancer research and omics-based biomarker discovery. His major funding comes from the Swedish Research Council, the Swedish Allergy and Cancer fund and five EU-FP-7 and H2020 program(s) emanating projects in the chemicals and nanomaterials safety assessment area. Roland Grafström is also a founder, board member and part-owner of Cercon AB, a company devoted to biomedical consulting (1983-current), and Predictomics AB, a company devoted to biomarker assisted prediction and testing of human health (2008-current).